Cover Image

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints

Fuente: arXiv

Saved in:

Bibliographic Details
Main Author:	Kelter, Riko
Format:	Preprint
Published:	2026
Subjects:	Methodology Applications
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

The Bayesian optimal two-stage design for clinical phase II trials based on Bayes factors
by: Kelter, Riko, et al.
Published: (2025)

Bayesian Power and Sample Size Calculations for Bayes Factors in the Binomial Setting
by: Kelter, Riko, et al.
Published: (2025)

Evaluating the impact of outcome delay on the efficiency of two-arm group-sequential trials
by: Mukherjee, Aritra, et al.
Published: (2023)

Bayesian sequential analysis of adverse events with binary data
by: Wang, Jiayue, et al.
Published: (2025)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
by: Maity, Arnab Kumar, et al.
Published: (2024)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
by: Long, James P., et al.
Published: (2025)

Two-stage Adaptive Design Cluster Randomised Trials
by: Watson, Samuel I., et al.
Published: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

Sparse two-stage Bayesian meta-analysis for individualized treatments
by: Shen, Junwei, et al.
Published: (2024)

Optimal scheduling of interim analyses in group sequential trials
by: He, Zhangyi, et al.
Published: (2025)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)

A multi-arm multi-stage design for trials with all pairwise testing
by: Greenstreet, Peter, et al.
Published: (2025)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023)

A scalable two-stage Bayesian approach accounting for exposure measurement error in environmental epidemiology
by: Lee, Changwoo J., et al.
Published: (2024)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)

Using off-treatment sequential multiple imputation for binary outcomes to address intercurrent events handled by a treatment policy strategy
by: Rehal, Sunita, et al.
Published: (2025)

A non-parametric U-statistic testing approach for multi-arm clinical trials with multivariate longitudinal data
by: Ghosh, Dhrubajyoti, et al.
Published: (2024)

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
by: Lyu, Jiaying, et al.
Published: (2020)

Evaluation of Surrogate Endpoints Based on Meta-Analysis with Surrogate Indices
by: Stijven, Florian, et al.
Published: (2025)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)

An information metric for comparing and assessing informative interim decisions in sequential clinical trials
by: Caruso, G., et al.
Published: (2025)

Simulation-based Bayesian predictive probability of success for interim monitoring of clinical trials with competing event data: two case studies
by: Micoli, Chiara, et al.
Published: (2024)

Eliciting prior information from clinical trials via calibrated Bayes factor
by: Demartino, Roberto Macrì, et al.
Published: (2024)

A Bayesian joint model of multiple nonlinear longitudinal and competing risks outcomes for dynamic prediction in multiple myeloma: joint estimation and corrected two-stage approaches
by: Alvares, Danilo, et al.
Published: (2024)

Bayesian Design and Analysis of Precision Trials with Partial Borrowing
by: Golchi, Shirin, et al.
Published: (2026)

Mesoscale two-sample testing for networks
by: MacDonald, Peter W., et al.
Published: (2024)

Tutorial for Surrogate Endpoint Validation Using Joint modeling and Mediation Analysis
by: Coent, Quentin Le, et al.
Published: (2025)

Multi-Dimensional Composite Endpoint Analysis via the Choquet Integral: Block Recurrent Encoding and Comparative Advantage Mapping
by: Tanboga, Ibrahim Halil
Published: (2026)

Nonparametric causal inference for optogenetics: sequential excursion effects for dynamic regimes
by: Loewinger, Gabriel, et al.
Published: (2024)

Optimal Experimental Design for Microplastics Sampling Experiments
by: Aquino-López, Marco A., et al.
Published: (2025)

Asymptotics of numerical integration for two-level mixed models
by: Stringer, Alex, et al.
Published: (2022)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026)

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
by: Yuan, Shijie, et al.
Published: (2025)

Increasing power and robustness in screening trials by testing stored specimens in the control arm
by: Katki, Hormuzd A., et al.
Published: (2024)

An Estimator-Robust Design for Augmenting Randomized Controlled Trial with External Real-World Data
by: Qiu, Sky, et al.
Published: (2025)

Cumulative Logit Ordinal Regression with Proportional Odds under Nonignorable Missing Response -- Application to Phase III Trial
by: Maity, Arnab Kumar, et al.
Published: (2025)